News | September 01, 2010

Coronary Zotarolimus-Eluting Stent Launched in Europe


September 1, 2010 - A new zotarolimus-eluting coronary stent using a biocompatible polymer gained CE mark and is being launched in Europe this week. The Medtronic Resolute Integrity Stent System features a novel drug-eluting coronary stent with good deliverability, the ability of the device to traverse the patient’s vasculature and reach the blockage in the heart artery.

Based on the engineering advance of continuous sinusoid technology, the Resolute has been shown in bench testing and in blind in-vivo physician assessment studies to be significantly more deliverable than the current market-leading alternatives.

“Medtronic stents built on continuous sinusoid technology are noticeably more deliverable, giving me greater confidence that I can reach the target lesion, even in patients with especially tortuous anatomy or narrow vessels,” said Dr. Neal Uren, consultant cardiologist at Lothian University Hospitals NHS Trust, Royal Infirmary of Edinburgh, U.K., and honorary senior lecturer at the University of Edinburgh in Scotland. “It’s a significant innovation for the clinical practice of interventional cardiology that sets a new gold-standard for deliverability.”

Coupled with the MicroTrac delivery system, continuous sinusoid technology improves deliverability without compromising other important stent design characteristics, like radial strength. It also improves the stent’s conformability, the ability of the stent to conform to the natural shape of the vessel and maintain apposition to the vessel wall after inflation with the balloon catheter.

The Resolute Integrity drug-eluting stent (DES) combines continuous sinusoid technology with two key elements of the original Resolute DES: the cytostatic antiproliferative drug zotarolimus and the highly biocompatible BioLinx polymer.

For more information: www.medtronic.com


Additional Content

News | Stents

Nov. 24, 2025 — InspireMD, Inc., developer of the CGuard Prime carotid stent system for the prevention of stroke ...

Home November 24, 2025
Home
News | Stents

Oct. 13, 2025 — Medtronic plc recently announced it has received U.S. Food and Drug Administration (FDA) labeling ...

Home October 13, 2025
Home
News | Stents

Oct. 16, 2024 — Sahajanand Medical Technologies (SMT) recently announced the publication of the COMPARE 60/80 HBR trial ...

Home October 16, 2024
Home
News | Stents

June 12, 2024 — Royal Philips, a global leader in health technology, announced the first implant of the Duo Venous Stent ...

Home June 12, 2024
Home
News | Stents

June 4, 2024 — A patient at HonorHealth Research Institute is one of the nation’s first — and the first in Arizona and ...

Home June 04, 2024
Home
Subscribe Now